MiniMed (MMED) Cost of Revenue (2025 - 2026)
MiniMed (MMED) posted Cost of Revenue of $357.0 million for Q2 2026, down 16.59% on a QoQ basis from $428.0 million in Q1 2026, and up 12.26% year-over-year from $318.0 million in Q2 2025.
MiniMed (MMED) Cost of Revenue (2025 - 2026) Analysis & Trends
MiniMed's Cost of Revenue history runs 2 years deep, the most recent figure standing at $357.0 million for Q2 2026.
- Quarterly Cost of Revenue rose 12.26% year-over-year to $357.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.4 billion (changed N/A YoY) and the FY2026 annual result came in at $1.4 billion, up 19.8% from the prior year.
- Cost of Revenue was $357.0 million for Q2 2026 at MiniMed, down from $428.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $428.0 million in Q1 2026 and bottomed at $292.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 220.92 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 260.92 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 98.33 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 28.07 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 44.67 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 357.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 97.04 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 19.41 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | - |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn | 169.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 357.00 Mn |
| Apr 24, 2026 | 357.00 Mn |
| Jan 23, 2026 | 428.00 Mn |
| Jan 23, 2026 | 428.00 Mn |
| Apr 25, 2025 | 318.00 Mn |
| Apr 25, 2025 | 318.00 Mn |
| Jan 24, 2025 | 292.00 Mn |
| Jan 24, 2025 | 292.00 Mn |